BRNS logo

Barinthus Biotherapeutics (BRNS) Operating Profit

Annual Operating Profit

-$80.45 M
-$77.65 M-2772.30%

31 December 2023

BRNS Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Operating Profit

-$8.77 M
+$8.82 M+50.14%

30 September 2024

BRNS Quarterly Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Operating Profit

-$62.13 M
+$6.13 M+8.98%

30 September 2024

BRNS TTM Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BRNS Operating Profit Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-2772.3%+41.1%+27.8%
3 y3 years-379.8%+43.3%-50.7%
5 y5 years---

BRNS Operating Profit High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-2772.3%at low-162.4%+66.0%-1011.2%+27.8%
5 y5 years-2772.3%at low-162.4%+66.0%-1011.2%+27.8%
alltimeall time-2772.3%at low-162.4%+66.0%-1011.2%+27.8%

Barinthus Biotherapeutics Operating Profit History

DateAnnualQuarterlyTTM
Sept 2024
-
-$8.77 M(-50.1%)
-$62.13 M(-9.0%)
June 2024
-
-$17.59 M(+7.8%)
-$68.26 M(-10.7%)
Mar 2024
-
-$16.32 M(-16.1%)
-$76.45 M(-5.0%)
Dec 2023
-$80.45 M(+2772.3%)
-$19.45 M(+30.5%)
-$80.45 M(-6.5%)
Sept 2023
-
-$14.90 M(-42.2%)
-$86.01 M(+33.1%)
June 2023
-
-$25.78 M(+26.8%)
-$64.60 M(+160.9%)
Mar 2023
-
-$20.33 M(-18.7%)
-$24.76 M(+807.5%)
Dec 2022
-$2.80 M
-$25.00 M(-484.0%)
-$2.73 M(-140.0%)
Sept 2022
-
$6.51 M(-53.7%)
$6.82 M(-259.7%)
June 2022
-
$14.06 M(+726.1%)
-$4.27 M(-87.6%)
DateAnnualQuarterlyTTM
Mar 2022
-
$1.70 M(-111.0%)
-$34.30 M(-16.8%)
Dec 2021
-$41.22 M(+145.8%)
-
-
Dec 2021
-
-$15.46 M(+237.7%)
-$41.22 M(+17.4%)
Sept 2021
-
-$4.58 M(-71.3%)
-$35.11 M(+15.7%)
June 2021
-
-$15.97 M(+206.1%)
-$30.35 M(+68.3%)
Mar 2021
-
-$5.22 M(-44.2%)
-$18.03 M(+7.6%)
Dec 2020
-$16.77 M
-$9.34 M(-5177.7%)
-$16.77 M(+125.8%)
Sept 2020
-
$184.00 K(-105.0%)
-$7.42 M(-2.4%)
June 2020
-
-$3.66 M(-7.4%)
-$7.61 M(+92.6%)
Mar 2020
-
-$3.95 M
-$3.95 M

FAQ

  • What is Barinthus Biotherapeutics annual operaing income?
  • What is the all time high annual operating profit for Barinthus Biotherapeutics?
  • What is Barinthus Biotherapeutics annual operating profit year-on-year change?
  • What is Barinthus Biotherapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for Barinthus Biotherapeutics?
  • What is Barinthus Biotherapeutics quarterly operating profit year-on-year change?
  • What is Barinthus Biotherapeutics TTM operating income?
  • What is the all time high TTM operating profit for Barinthus Biotherapeutics?
  • What is Barinthus Biotherapeutics TTM operating profit year-on-year change?

What is Barinthus Biotherapeutics annual operaing income?

The current annual operating profit of BRNS is -$80.45 M

What is the all time high annual operating profit for Barinthus Biotherapeutics?

Barinthus Biotherapeutics all-time high annual operaing income is -$2.80 M

What is Barinthus Biotherapeutics annual operating profit year-on-year change?

Over the past year, BRNS annual operaing income has changed by -$77.65 M (-2772.30%)

What is Barinthus Biotherapeutics quarterly operating income?

The current quarterly operating profit of BRNS is -$8.77 M

What is the all time high quarterly operating profit for Barinthus Biotherapeutics?

Barinthus Biotherapeutics all-time high quarterly operating income is $14.06 M

What is Barinthus Biotherapeutics quarterly operating profit year-on-year change?

Over the past year, BRNS quarterly operating income has changed by +$6.13 M (+41.13%)

What is Barinthus Biotherapeutics TTM operating income?

The current TTM operating profit of BRNS is -$62.13 M

What is the all time high TTM operating profit for Barinthus Biotherapeutics?

Barinthus Biotherapeutics all-time high TTM operating income is $6.82 M

What is Barinthus Biotherapeutics TTM operating profit year-on-year change?

Over the past year, BRNS TTM operating income has changed by +$23.88 M (+27.76%)